Dickkopf1 Promotes Pulmonary Fibrosis upon Bleomycin-Induced Lung Injury
The American Journal of Pathology · 2023
DOI: 10.1016/j.ajpath.2023.05.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2023. Verfasst von Eun-Ah Sung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Massey Cancer Center, Virginia Co…. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Lung Injury, Pneumonia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, Virginia Commonwealth University.
Abstract (Originalsprache)
Orchestration of inflammation and tissue repair processes is critical to maintaining homeostasis upon tissue injury. Tissue fibrosis is a pathological process characterized by aberrant accumulation of extracellular matrix proteins, such as collagen, upon injury. Dickkopf1 (DKK1) is a quintessential Wnt antagonist. The role of DKK1 in bleomycin (BLM)-induced lung injury and fibrosis model remains elusive. This study shows that BLM-induced lung injury markedly elevated DKK1 protein expressions in the lungs in mice, consistent with human pulmonary fibrosis patient lung tissues. The elevated DKK1 levels coincided with immune cell infiltration and collagen deposition. Notably, the reduced expression of DKK1 in Dkk1 hypomorphic doubleridge (Dkk1d/d) mice abrogated BLM-induced lung inflammation and fibrosis. Immune cell infiltration, collagen deposition, expression of profibrotic cytokine transforming growth factor β1 (TGF-β1), and extracellular matrix protein-producing myofibroblast marker α-smooth muscle actin (α-SMA) were reduced in Dkk1d/d mice. Consistent with these results, local DKK1 antibody administration after BLM-induced lung injury substantially decreased lung inflammation and fibrosis phenotypes. Taken together, these results demonstrate that DKK1 is a proinflammatory and profibrotic ligand that promotes inflammation and fibrosis upon BLM-induced lung injury, placing it as an attractive molecular target for dysregulated pulmonary inflammation and tissue repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
- Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut.
- Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virgini…
- Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia. Electron…
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- Virginia Commonwealth University
- National Institutes of Health
- American Cancer Society
- NCI
Zitieren
APA
Sung, E. A., Park, M. H., Henegariu, O., Sime, P. J., & Chae, W. J. (2023). Dickkopf1 Promotes Pulmonary Fibrosis upon Bleomycin-Induced Lung Injury. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2023.05.009
Vancouver
Sung EA, Park MH, Henegariu O, Sime PJ, Chae WJ. Dickkopf1 Promotes Pulmonary Fibrosis upon Bleomycin-Induced Lung Injury. The American Journal of Pathology. 2023. doi:10.1016/j.ajpath.2023.05.009
BibTeX
@article{Sung2023,
author = {Sung, Eun-Ah and Park, Min Hee and Henegariu, Octavian and Sime, Patricia J and Chae, Wook-Jin},
title = {Dickkopf1 Promotes Pulmonary Fibrosis upon Bleomycin-Induced Lung Injury},
journal = {The American Journal of Pathology},
year = {2023},
doi = {10.1016/j.ajpath.2023.05.009}
}
EUVIMED